CLINICAL_TRIALS
trial_result
· 2021-03-29
Clinical Trial Update: A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes
Summary
A completed clinical trial update analyzing characteristics of people taking empagliflozin for type 2 diabetes based on German registry data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2021-03-29